[prisna-google-website-translator]
Medical Darpan Medical Darpan Media HouseIndia’s most leading Pharma Portal
Medical Darpan Medical Darpan Media HouseIndia’s most leading Pharma Portal
  • Home
  • Interview
  • Editorial
  • Blog
    • Belly Fat
    • Benefits Of
    • Careers
    • COVID-19
    • Diabetes
    • Differences
    • Diseases
    • Exercises Tips
    • Fitness Gadgets
    • Hair Tips
    • Health and Fitness Tips
    • Healthy Food
    • Healthy Fruits
    • Masks
    • Pharma Industries
    • Pharma Trends
    • Pharmacy College
    • Pregnancy
    • Sexual Wellness
    • Skin Care
  • Features
    • Startups
    • Trends
    • Product Review
    • Press-Releases
  • E-paper
  • Videos
  • About us
  • Calculator
    • BMI Calculator
    • Calorie burn rate calculator
    • Ovulation Calculator
    • Due Date Calculator
  • Contact us
  • For advertising Queries please call 9899152321 or email sales@medicaldarpan.com
  • Posted on 20 Jan, 2022
    Fermenta has signed a Definitive Agreement with Aurigene, a stepdown subsidiary of Dr Reddy’s Laboratories Limited

    Fermenta Biotech Limited (FBL) today announced that it has signed a Definitive Agreement with Aurigene Pharmaceutical Services Limited (APSL), a stepd...

  • Posted on 10 Jan, 2022
    Alembic Pharmaceuticals receives USFDA Tentative Approval for Dronedarone Tablets

    Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) f...

  • Posted on 8 Jan, 2022
    AMGEN TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

    THOUSAND OAKS, Calif., Jan. 6, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will virtually present at the 40th Annual J.P. Morgan Healthcare Conference...

  • Posted on 7 Jan, 2022
    NATCO Pharma Limited has been awarded Corporate Governance Award

    NATCO Pharma Limited (the Company) pleased to inform that the Company has been awarded Corporate Governance Award for the year 2021 at the virtual eve...

  • Posted on 7 Jan, 2022
    Lupin launches Molnupiravir under the brand name Molnulup for the treatment of COVID-19 in adults in India

    Mumbai, India, January 07, 2022: Global pharma major Lupin Limited (Lupin) announced the launch of Molnupiravir in India under the brand name Molnulu...

  • Posted on 6 Jan, 2022
    Amgen and Generate Biomedicines Announce Multi-Target, Multi-Modality Research Collaboration Agreement

    THOUSAND OAKS, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 6, 2022-- Amgen (NASDAQ: AMGN) and Generate Biomedicines today announced a res...

  • Posted on 5 Jan, 2022
    Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United States

    NEW HAVEN, Conn., and NEW YORK, January 5, 2022 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) and Pfizer Inc. (NYSE: PFE),...

  • Posted on 1 Jan, 2022
    NATCO completes acquisition of Dash Pharmaceuticals LLC01 January 2022

    NATCO Pharma Inc. USA, a wholly owned subsidiary of NATCO Pharma Limited (NSE: NATCOPHARM; BSE: 524816) (“NATCO”), has completed the acquisition o...

  • Posted on 28 Dec, 2021
    Torrent Pharma to launch Molnupiravir under the brand name Molnutor® in India

    Torrent Pharma has today announced that it is introducing MSD (a trade name of Merck & Co., Inc, Kenilworth, NJ, USA) and Ridgeback’s molnupirav...

  • Posted on 28 Dec, 2021
    Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India

    Mumbai, December 28, 2021: Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” a...

  • Posted on 23 Dec, 2021
    FedEx Marks Anniversary of First COVID-19 Vaccine Deliveries

    INDIA, December 15, 2021 – One year ago, FedEx Express, a subsidiary of FedEx Corp. (NYSE: FDX) and one of the world’s largest express transporta...

  • Posted on 23 Dec, 2021
    The new edition adds success and sets the benchmark to Indian Pharma Expo 2021

    Indian Pharma Expo 2021 was held on 10th and 11th December at Pragati Maidan, New Delhi with complete COVID-19 guidelines.  The 10th edition was i...

  • Posted on 20 Dec, 2021
    FDA APPROVES OTEZLA® (APREMILAST) FOR THE TREATMENT OF ADULT PATIENTS WITH PLAQUE PSORIASIS, REGARDLESS OF SEVERITY LEVEL

    THOUSAND OAKS, Calif., Dec. 20, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approve...

  • Posted on 19 Dec, 2021
    Cipla Receives Final Approval for Lanreotide Injection

    Mumbai, India, & New Jersey, USA: December 19, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla")and its subs...

  • Posted on 16 Dec, 2021
    Cipla acquires stake in Clean Max Auriga Power LLP; progresses towards championing its ESG agenda

    Mumbai, India; December 15, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla") announced today that it has acquir...

  • Posted on 15 Dec, 2021
    Only 12.5% home care patients use manually adjustable beds which aid in healing according to a recent study by Godrej Interio

    Mumbai, 15th December 2021: Godrej & Boyce, the flagship company of the Godrej Group, announced that its business Godrej Interio, India’s leadi...

  • Posted on 15 Dec, 2021
    Aragen acquires Intox Pvt. Ltd.

    15 December 2021: Aragen Life Sciences, a global research, development, and manufacturing solutions provider (CRO/CDMO), announced that it has signed ...

  • Posted on 2 Dec, 2021
    ICPA Clinical Series’ Latest Episode Focuses On Achieving Growth In The Early Years Of Dental Practice

    Mumbai: India's leading Pharma Company in the oral healthcare segment - ICPA Health Products Ltd (ICPA) hosted its sixth interactive online session in...

  • Posted on 27 Oct, 2021
    Phillips-Medisize Increases Global Manufacturing Capacity, Capabilities and Collaborations to Drive Drug Delivery, Diagnostic and MedTech Innovations

    HUDSON, WI – October 27, 2021 – Phillips-Medisize, a Molex company and leader in the design and manufacture of drug delivery, diagnostic, and Me...

  • Posted on 27 Oct, 2021
    MedicalTech Innovation Forum magnifies the importance of innovation and infrastructure in the Indian medical devices industry

    Aligning with India’s goal of becoming a global hub for medical device manufacturing and innovation, Messe Frankfurt India and Andhra Pradesh MedTec...

  • Posted on 13 Oct, 2021
    Healthcare Innovation at IIMA Healthcare Alumni Special Interest Group and TiE Mumbai’s IIMPACT HEALTH 2021

    Mumbai, October 13, 2021: The Indian Institute of Management Ahmedabad’s Alumni-led Healthcare Special Interest Group and TiE Mumbai organized the c...

  • Posted on 13 Sep, 2021
    TiE Mumbai & IIMA Healthcare SIG presents IIMPACT HEALTH 2021 Global shifts, disruptions & The age of UNICORNS scaling Healthcare Innovation in India

    Mumbai, September 13, 2021: TiE Mumbai, in partnership with IIM Ahmedabad’s Alumni-led Healthcare Special Interest Group, is organizing a two-day co...

  • Posted on 13 Apr, 2021
    Alkem makes epilepsy treatment more accessible & affordable with the launch of Brivasure (Brivaracetam)

    Alkem Laboratories Ltd. (Alkem), one of India’s leading pharmaceutical formulation development, manufacturing, and marketing companies, announce the...

  • Posted on 13 Apr, 2021
    Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Final Approval for Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1 mg/gram.

    Alembic Pharmaceuticals Limited (Alembic) today announced that its joint venture Aleor Dermaceuticals Limited (Aleor) has received final approval from...

  • Posted on 13 Apr, 2021
    Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Tentative Approval for Efinaconazole Topical Solution, 10%.

    Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Tentative Approval for Efinaconazole Topical Solution, 10%. Al...

  • Posted on 13 Apr, 2021
    Lupin Launches Authorized Generic Version of Alinia

    Mumbai, Baltimore, March 10, 2021: Global pharma major, Lupin Limited (Lupin), today announced the launch of the authorized generic version of Alinia...

  • Posted on 13 Apr, 2021
    Piramal Enterprises Appoints Khushru Jijina to its Board as Executive Director, Financial Services

    Mumbai, India | April 2, 2021: We are pleased to share, that Khushru Jijina, Managing Director, Piramal Capital, will join the Board of Piramal Enterp...

  • Posted on 13 Apr, 2021
    Piramal Pharma Ltd. To Acquire 100% Stake in Hemmo Pharmaceuticals, a Leading Indian Manufacturer of Peptide APIs

    Piramal Pharma Limited’s (PPL) Contract Development and Manufacturing Organization (CDMO), Piramal Pharma Solutions (PPS), announced today that PPL ...

  • Posted on 13 Apr, 2021
    Piramal Pharma Solutions Enters Into a Master Services Agreement with Plus Therapeutics, Inc.

    Piramal Pharma Limited’s (PPL) Contract Development and Manufacturing Organization (CDMO), Piramal Pharma Solutions (PPS), announced today that the ...

  • Posted on 13 Apr, 2021
    Dr. Reddy’s launched Sapropterin Dihydrochloride Powder

    Hyderabad, India and Princeton, NJ, USA. April 7, 2021 - Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, NSEIFSC: DR REDDY alo...

  • Posted on 23 Mar, 2021
    Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats

    March 23, 2021, MUMBAI - Cipla Therapeutics, an affiliate of Cipla Limited (BSE: 500087; NSE: CIPLA EQ; referred to as "Cipla") and SIGA Technologies,...

  • Posted on 19 Mar, 2021
    Cipla pledges support to ‘Terra Carta’, for a sustainable future

    Mumbai; March 19, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that it has pledged support to ‘Terra...

  • Posted on 18 Mar, 2021
    Thermo Fisher Scientific Signs MoU with the National Forensic Sciences University to open ‘Center of Excellence’ in India

    Gandhinagar, India, March 18, 2021 – Thermo Fisher Scientific, the world leader in serving science, signed an MoU with the National Forensic Science...

  • Posted on 2 Mar, 2021
    Cipla receives final approval for generic version of GlaxoSmithKline’s IMITREX® (Sumatriptan Nasal Spray, 20 mg)

    Mumbai, India, March 02, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ hereinafter referred to as “Cipla”) today announced that it has received ...

  • Posted on 25 Feb, 2021
    Sun Pharma Launches Website for its Long-Term Care Portfolio in the U.S.

    Mumbai, India, and Princeton, NJ, February 25, 2021 – Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUN PHARMA, B...

  • Posted on 18 Feb, 2021
    New Thermo Fisher Scientific Manufacturing Facility in Bengaluru to Produce reliable COVID-19 Testing Kits in India for India 

    Bengaluru, India, Feb 18, 2021 – A new state-of-the-art Thermo Fisher Scientific manufacturing facility in Bengaluru will produce COVID-19 testing ...

  • Posted on 2 Feb, 2021
    Cipla celebrates 85 years with the launch of its book ‘Caring For Life: The Cipla Story Since 1935’

    Mumbai; February 02, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced the lauch of its book ‘Caring For L...

  • Posted on 2 Feb, 2021
    Lupin Announces Appointment of New Independent Director

    Mumbai, India, February 2, 2021: Lupin Limited (Lupin), the global pharmaceutical company, announced the appointment of Mr. Mark D. McDade as an Indep...

  • Posted on 25 Jan, 2021
    Lupin Receives Approval for Sevelamer Carbonate Tablets

    Mumbai, Baltimore, January 25, 2021: Lupin Limited (Lupin), global pharmaceutical company, announced today that it has received approval for its Sevel...

  • Posted on 22 Jan, 2021
    Alembic Pharmaceuticals announces USFDA Final Approval for Midodrine Hydrochloride Tablets USP, 2.5 mg, 5 mg, and 10 mg

    Alembic Pharmaceuticals Limited (Alembic) today announced it has received approval from the US Food & Drug Administration (USFDA) for its Abbrevia...

  • Posted on 21 Jan, 2021
    Professor Peter Piot Joins the Board of Biocon Biologics Limited as an Independent Director

    Biocon Biologics Ltd., a fully integrated ‘pure-play’ biosimilars company and a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), anno...

  • Posted on 11 Jan, 2021
    Sanofi to acquire Kymab, adding KY1005 to its pipeline, a human monoclonal antibody targeting key immune system regulator OX40L

    PARIS and CAMBRIDGE, UK – January 11, 2021 – Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal anti...

  • Posted on 6 Jan, 2021
    Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP

    Mumbai, Baltimore, January 6, 2021: Lupin Limited (Lupin), global pharmaceutical company, announced today that it has received approval for its Sulfam...

  • Posted on 1 Nov, 2020
    Swedish temperature monitoring solutions provider, TSS, appoints new regional manager for Middle East & India operations

    Swedish provider of temperature monitoring solutions for the life science industry appoints Christopher Hobeiche to oversee its operations in the Midd...

  • Posted on 22 Oct, 2020
    Helmet Brand Steelbird ventures out Healthcare Business

    New Delhi, 20th October, 2020: Asia's largest helmet manufacturer Steelbird Hi-tech India (SBHT) apart from producing its popular range of motorcycle...

  • Posted on 22 Oct, 2020
    8.50 lac MEMBERS OF AIOCD ARE READY TO SUPPLY COVID VAACINE 

    All India Organisation of Chemists and Druggists have Appealed to Prime Minister to utilize established supply chain for vaccine distribution through ...

  • Posted on 22 Oct, 2020
    Issar Pharma Develops First-ever Peptide Molecule for Skin Care “Mission Molecules”

    India’s first-ever peptide molecule for the treatment of Vitiligo was developed way back in 2004 and the second peptide New Chemical Entity (NCE) wh...

  • Posted on 28 Aug, 2020
    Lupin and Mylan Launch Nepexto®, Biosimilar Etanercept in Germany

    Mumbai, India | BAD HOMBURG, Germany, August 26, 2020: Lupin Limited (Lupin) and Mylan N.V. (NASDAQ: MYL) announced today the launch of Nepexto®, ...

  • Posted on 25 Aug, 2020
    Lupin Receives Approval for Generic Albuterol Sulphate MDI

    Mumbai, Baltimore, August 25, 2020: Pharma major Lupin Limited (Lupin) announced today that it has received approval from the United States Food and D...

  • Posted on 11 Aug, 2020
    Lupin Launches Zileuton Extended-Release Tablets

    Mumbai, Baltimore, August 11, 2020: Pharma major Lupin Limited (Lupin) announced the launch of Zileuton Extended-Release Tablets, 600 mg, having recei...

  • Posted on 5 Aug, 2020
    Lupin Launches Favipiravir Drug Covihalt® for Treatment of Mild to Moderate COVID-19

    Mumbai, India, August 05, 2020: Pharma major Lupin Limited (Lupin) today announced the launch of its Favipiravir in India under the brand name Covihal...

  • Posted on 8 Jul, 2020
    Virtual Patient Experience Innovation Summit 2020

    The Patient Experience Innovation Summit will be held on the 13th of July 2020, as a virtual webinar, giving attendees an opportunity to stay in touch...

  • Posted on 2 Jun, 2020
    Mankind Pharma launches drug for treatment of infertility in India

    With the launch, the company has become the first Indian and second global firm to develop the drug, Mankind Pharma said in a statement. Drug fir...

  • Posted on 2 Jun, 2020
    GSK announces intention to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborations

    GSK today confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant system, in 2021, to support the development of multi...

  • Posted on 2 Jun, 2020
    Lupin Receives Approval for Meloxicam Capsules

    Mumbai, Baltimore, June 02, 2020: Pharma major Lupin Limited (Lupin) announced that it has received approval for its Meloxicam Capsules, 5 mg and 10 m...

  • Posted on 25 May, 2020
    Alembic Pharmaceuticals announces USFDA Final Approval for Doxycycline Hyclate Tablets USP, 100 mg

    Alembic Pharmaceuticals Limited (Alembic) announced it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated Ne...

  • Posted on 25 May, 2020
    AIRZ-FF : Glenmark introduces 3-in-1 inhaler therapy for COPD in India

      AIRZ-FF is India’s first Glycopyrronium + Formoterol + Fluticasone combination, exclusively studied in the Indian population Backed b...

  • Posted on 23 May, 2020
    Cipla receives final approval for generic version of Migranal® (Dihydroergotamine Mesylate Nasal Spray 4mg/mL) with a Competitive Generic Therapy Designation

    Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla")  announced that it has received final approval for its Abbreviated N...

  • Posted on 23 May, 2020
    Dupixent® (dupilumab) eosinophilic esophagitis trial shows positive results

      Dupixent demonstrated significant clinical and anatomic improvements, including the ability to swallow, in Part A of the pivotal trial ...

  • Posted on 18 May, 2020
    Dr. Reddy’s Laboratories announces the launch of FXR™ (obeticholic acid) in India

    Dr. Reddy’s Laboratories Ltd., announced the launch of FXR™, a therapeutic equivalent generic version of Ocaliva® (obeticholic acid) in Indi...

  • Posted on 8 May, 2020
    Zydus Cadila Launches Enzalutamide, making Prostate Cancer therapy highly affordable

     The therapy priced at nearly two-thirds the cost of the currently available products in the market Developed in-house, the drug offers bio-availa...

  • Posted on 6 May, 2020
    Dr. Reddy’s Laboratories announces the launch of Desmopressin Acetate Injection USP

    Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today...

  • Posted on 5 May, 2020
    Glenmark receives approval from (DCGI) to conduct Clinical Trials in India on Favipiravir Antiviral tablets for COVID-19 patients

    Glenmark has successfully developed the API and the formulations for the product through its in-house R&D team Mumbai, India; Glenmark Pharmace...

  • Posted on 19 Apr, 2020
    COVID-19:  Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries 

    Sanofi to provide Plaquenil® (hydroxychloroquine) wherever possible while securing appropriate supply levels for currently approved indications; T...

  • Posted on 19 Apr, 2020
    Sanofi and Luminostics to join forces on developing breakthrough COVID-19 smartphone-based self-testing solution

    • Companies to negotiate a collaboration on the development of a breakthrough COVID-19 self-test solution based on Luminostics’ proprietary techno...

  • Posted on 19 Apr, 2020
    Glenmark Pharmaceuticals receives ANDA tentative approval for Dapagliflozin Tablets, 5 mg and 10 mg

    March 23, 2020: Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration ...

  • Posted on 19 Apr, 2020
    Glenmark divests VWash, a female intimate hygiene wash, to Hindustan Unilever

     As part of the agreement, Glenmark’s VWash brand will be transferred to Hindustan Unilever Limited (‘HUL’) Glenmark Pharmaceuticals Ltd, a ...

  • Posted on 19 Apr, 2020
    Alembic Group commits Rs.10 crore towards the COVID 19 Pandemic

    The 112 year old Alembic Group, based in Vadodara has stepped up its humanitarian effort and announced an allocation of Rs. 10 crore towards the COVID...

  • Posted on 19 Apr, 2020
    Sun Pharma Commits Donation of Medicines and Hand Sanitizers to Support India’s COVID-19 Pandemic Response

    Mumbai, India, March 27, 2020 – Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUN PHARMA, BSE: 524715, “Sun Pharma...

  • Posted on 19 Apr, 2020
    Dr. Reddy’s statement on the COVID-19 pandemic

    Tuesday, April 14, 2020 As the COVID-19 pandemic continues to impact the world around us, Dr. Reddy’s is addressing this unprecedented challenge ...

  • Posted on 19 Apr, 2020
    COVID-19: Piramal Group commits Rs 25 cr donation to PM fund

    Piramal Foundation, the group's philanthropic arm that has a presence in 25 states across India continues to work in partnership with the government, ...

  • Posted on 19 Apr, 2020
    Dr. Reddy’s Laboratories announces the launch of Invista® (dasatinib) in India Hyderabad, India

    Hyderabad, India, April 13, 2020 — Dr. Reddy’s Laboratories Ltd., today announced the launch of Invista®, a formulation of Dasatinib that is bioe...

  • Posted on 19 Apr, 2020
    Mankind Pharma pledge to contribute Rs 51 crore for Covid-19 relief fund

    As coronavirus cases continue to grow in India, pharmaceutical company Mankind Pharma has donated Rs 51 crore to CM Relief Funds to fight the deadly v...

  • Posted on 16 Apr, 2020
    Zenfold Ventures takes equity stake in Esperer Onco Nutrition

    Mumbai, April 15, 2020: Esperer Onco Nutrition Pvt Ltd (EON), a pioneer in bringing a comprehensive nutritional portfolio to oncology, announced a sig...

  • Posted on 16 Apr, 2020
    How And Why You Should Install Arogya Setu App During COVID-19 Times 

    Aarogya Setu App, was launched by the government of India for coronavirus tracking  The motive behind developing this app is to help individuals iden...

  • Posted on 19 Mar, 2020
    ASIA PHARMA EXPO 2020 concluded with completing 18 successful years !!

    APE 2020 emerged as the technology solution provider business event with its 12th edition providing trade platform for 628 exhibiting companies from 2...

Latest Blog
  • Menstrual Discomfort: Causes, Types, Relief, and When to Seek Help
  • Home Remedies And Precautions For Conjunctivitis Management aka Pink Eye
  • Staying Healthy and Active While Traveling: Tips for a Happy Journey
  • How Is IVF Different From Natural Pregnancy
  • Revealing the Power of Horsegram: Health Benefits and Culinary Delights
More Blog
Advertisement
advertise-img
Twitter Feed
Tweets by DarpanMedical
Newsletter Subscription

    Advertisement

    Copyright © 2023 Medical Darpan

    • About us
    • Contact us
    • News Upload
    • Helpdesk
    • Privacy Policy
    • Sitemap